Detalles de la búsqueda
1.
Tackling cancer cell dormancy: Insights from immune models, and transplantation.
Semin Cancer Biol
; 78: 5-16, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33582171
2.
Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies.
Cancer Immunol Immunother
; 69(5): 683-687, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32152702
3.
Exploiting autoimmunity unleashed by low-dose immune checkpoint blockade to treat advanced cancer.
Scand J Immunol
; 90(6): e12821, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31589347
4.
MiStImm: an agent-based simulation tool to study the self-nonself discrimination of the adaptive immune response.
Theor Biol Med Model
; 16(1): 9, 2019 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31046789
5.
Effective multiple oral administration of reverse genetics engineered infectious bursal disease virus in mice in the presence of neutralizing antibodies.
J Gene Med
; 17(6-7): 116-31, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25929556
6.
Control of minimal residual cancer by low dose ipilimumab activating autologous anti-tumor immunity.
Pharmacol Res
; 79: 9-12, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24200897
7.
Association of Baseline Tumor-Specific Neoantigens and CD8+ T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors.
JCO Precis Oncol
; 8: e2300439, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38330262
8.
A novel method of CD34+ cell separation from umbilical cord blood.
Transfusion
; 53(11): 2675-80, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23432618
9.
Combination Therapy for the Treatment of Shingles with an Immunostimulatory Vaccine Virus and Acyclovir.
Pharmaceuticals (Basel)
; 16(2)2023 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37259374
10.
Interesting possibilities to improve the safety and efficacy of ipilimumab (Yervoy).
Pharmacol Res
; 66(2): 192-7, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22503629
11.
An Orally Administered Nonpathogenic Attenuated Vaccine Virus Can Be Used to Control SARS-CoV-2 Infection: A Complementary Plan B to COVID-19 Vaccination.
Cureus
; 14(8): e28467, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36176842
12.
A Clinically Validated, Broadly Active, Oral Viral Superinfection Therapy Could Mitigate Symptoms in Early-stage COVID-19 Patients.
Infect Disord Drug Targets
; 22(7): 1-6, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35440336
13.
Sequential Combination of a Strong Interferon Inducer Viral Vector With Low Doses of Nivolumab Plus Ipilimumab Could Provide Functional Cure in Chronic Hepatitis B Virus infections: Technical Report Proposing a New Modality.
Cureus
; 14(3): e22750, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35371882
14.
Healing of Severe Herpes Zoster Ophthalmicus Within a Few Days: An Autobiographical Case Report.
Cureus
; 13(12): e20303, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35024256
15.
Complete Remission of Vocal Cord Cancer Treated With Low-Dose Ipilimumab Plus Nivolumab Combined With Interleukin-2 and Hyperthermia.
Cureus
; 13(4): e14500, 2021 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34007753
16.
Breast and other cancer dormancy as a therapeutic endpoint: speculative recombinant T cell receptor ligand (RTL) adjuvant therapy worth considering?
BMC Cancer
; 10: 251, 2010 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-20525172
17.
Therapeutic Exploitation of Viral Interference.
Infect Disord Drug Targets
; 20(4): 423-432, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-30950360
18.
Reduction in high blood tumor necrosis factor-alpha levels after manipulative therapy in 2 cervicogenic headache patients.
J Manipulative Physiol Ther
; 32(7): 586-91, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19748410
19.
Improved cardiorespiratory fitness following moderate exercise may encourage inactive people for doable and sustainable behavioral change.
J Sports Med Phys Fitness
; 59(3): 502-509, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29589406
20.
Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs.
Hepatol Med Policy
; 3: 2, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30288325